Inventor · disambiguated record
Stephen Joseph Pakola
Also filed as: PAKOLA STEPHEN · PAKOLA STEPHEN JOSEPH
1 granted patent·11 pending applications·1 citations·filing 2019–2023
17Inventor score
Top patents by PatentIndex Score
12 records- 0178US11986515B2Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS)REGENXBIO INC·Filed 2023·Granted May 21, 2024·1 cites·30 claims
- 0254US2024117328A1Treatment of mucopolysaccharidosis ii with recombinant human iduronate-2-sulfatase (ids)REGENXBIO INC·Filed 2022·Application pending·0 cites
- 0352US2025339555A1Formulations for suprachoroidal administration such as formulations with aggregate formationREGENXBIO INC·Filed 2023·Application pending·0 cites
- 0445US2024024508A1Formulations for suprachoroidal administration such as high viscosity formulationsREGENXBIO INC·Filed 2021·Application pending·0 cites
- 0545US2023414788A1Formulations for suprachoroidal administration such as gel formulationsREGENXBIO INC·Filed 2021·Application pending·0 cites
- 0644US2024091380A1Gene therapy for neuronal ceroid lipofuscinosesREGENXBIO INC·Filed 2022·Application pending·0 cites
- 0744US2019262321A1Methods of treating diabetic nephropathy using hptpb inhibitorsAERPIO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0842US2023372538A1Formulations for suprachoroidal administration such as formulations with aggregate formationREGENXBIO INC·Filed 2021·Application pending·0 cites
- 0941US2023364206A1Gene therapy for ocular manifestations of cln2 diseaseREGENXBIO INC·Filed 2021·Application pending·0 cites
- 1040US2023088992A1Treatment of mucopolysaccharidosis ii with recombinant human iduronate-2-sulfatase (ids) produced by human neural or glial cellsREGENXBIO INC·Filed 2021·Application pending·0 cites
- 1139US2022280608A1Treatment of diabetic retinopathy with fully-human post-translationally modified anti-vegf fabREGENXBIO INC·Filed 2020·Application pending·0 cites
- 1239US2023059395A1Treatment of mucopolysaccharidosis i with fully-human glycosylated human alpha-l-iduronidase (idua)REGENXBIO INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephen Joseph Pakola files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →